Search

everythinglearnresearchcommunity

for

Search:↓

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Pharmacy professionals need thorough training and guidelines for safely preparing cytotoxic drugs.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

Anthralin is effective for psoriasis and alopecia with minimal systemic side effects but can irritate the skin.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Chemotherapy causes complex changes in hair follicle cells that can lead to hair loss.

Alpha-tocopherol does not prevent hair loss from doxorubicin.

Most pediatric cancer patients at Muhimbili National Hospital in Tanzania experienced side effects from chemotherapy, with nausea, hair loss, and low white blood cell count being the most common.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

PLD is an effective and safer alternative for treating breast cancer.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.

The book concludes that despite progress, cancer drug treatments have not met the expectations set in the 1960s and 1970s.

Nurses are crucial in managing chemotherapy side effects for ovarian cancer patients to improve their quality of life.

Topical vasoconstrictors do not reduce chemotherapy effectiveness against leukemia in mice.

Doxycycline can effectively treat hair loss caused by EGFR inhibitors.

Some new drugs show potential for treating blood cancers but have serious side effects and need more research.

Chemoprevention is rarely used due to concerns about risks, side effects, and lack of clear guidelines.

Promising cancer treatments were found, but the manufacturer closed.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

MK-5108 is safe and shows potential against tumors, especially alone.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

Chemotherapy often causes skin, hair, and nail problems in cancer patients.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Preventing and managing skin issues from cancer treatment is crucial, especially in high UV areas like Australia and New Zealand.